10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of October 20, 2026, TXG trades at $69.89 with a market cap of $9.10B and a P/E ratio of -138.46. TXG moved -0.02% today. Year to date, TXG is +320.52%; over the trailing twelve months it is +490.79%. Its 52-week range spans $6.78 to $102.81. Analyst consensus is buy with an average price target of $75.73. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TXG, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $69.89 |
| Market Cap | $9.10B |
| P/E Ratio | -138.46 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $102.81 |
| 52-Week Low | $6.78 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $616.91M |
| Net Income | $-75.13M |
| Gross Margin | 70.03% |
16 analysts cover TXG: 0 strong buy, 7 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $75.73.